(Q37610419)

21 August 2017

1 reference

title

Role of CCR5 Delta32 bp deletion in RA and SLE. (English)

1 reference

21 August 2017

Martens HA

1

1 reference

21 August 2017

Kallenberg CG

series ordinal

2

1 reference

21 August 2017

Bijl M

series ordinal

3

1 reference

21 August 2017

publication date

1 May 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

42

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

260-262

1 reference

The geographic spread of the CCR5 Delta32 HIV-resistance allele

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Expression of the C-C chemokine receptor 5 in human kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902827926

10.1080/08916930902827926

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference